Cell density, proliferation, viability, morphology and mRNA expression were evaluated.
Data from protein and gene expression were evaluated using linear mixed effects models.
Cell proliferation, extracellular matrix production, and chondrogenic gene expression were evaluated after two and four weeks.
The clinical signs of locomotion, axonal morphometry and neurofilaments (NFs) expression were evaluated.
Proliferation indices and p53 expression were evaluated immunohistochemically, and the presence of human papillomavirus (HPV) DNA was determined by using polymerase chain reaction (PCR) amplification.
EXPERIMENTAL DESIGN: CD3+, CD4+, CD8+ TILs and MHC1, 2 expression were evaluated by immunohistochemistry on tissue microarrays in 113 paired primary and recurrent HGSOC.
To identify the active core structure, 25 derivatives of TrfA were synthesized and their inhibitory activities against auxin-inducible gene expression were evaluated.
Osteoblast-related markers, alkaline phosphatase (ALP) activity and bone sialoprotein (BSP) and osteopontin (OP) mRNA expression were evaluated in BMSCs following 14 days of cocultivation in both systems.
GLP-1R mRNA and protein expression were evaluated in the bone, bone marrow and bone cells using RT-PCR and immunohistochemistry.
Effects on SEC gene expression were evaluated by quantitative reverse-transcription polymerase chain reaction and immunoblotting.
Alterations in in vivo AE2 protein expression were evaluated in lung tissue of rats exposed to 70% O(2).
